| [1] |
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020, 396(10258): 1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
pmid: 33069326
|
| [2] |
中国医院协会临床微生物实验室专业委员会. 新发突发呼吸道传染性病原微生物分级检测专家共识(2024)[J]. 协和医学杂志, 2025, 16(1):109-124. doi: 10.12290/xhyxzz.2024-1006.
|
| [3] |
Deng F, Dong Z, Qiu T, et al. Respiratory pathogen dynamics in community fever cases: Jiangsu Province, China (2023-2024)[J]. Virol J, 2024, 21(1): 226.doi: 10.1186/s12985-024-02494-9.
|
| [4] |
Li H, Yang Y, Tao R, et al. Analyzing infections caused by 11 respiratory pathogens in children: Pre- and post-COVID-19 pandemic trends in China[J]. J Med Virol, 2024, 96(9): e299-309. doi: 10.1002/jmv.29929.
|
| [5] |
Zhao P, Zhang Y, Wang J, et al. Epidemiology of respiratory pathogens in patients with acute respiratory infections during the COVID-19 pandemic and after easing of COVID-19 restrictions[J]. Microbiol Spectr, 2024, 12(11): e0116124. doi: 10.1128/spectrum.01161-24. Epub 2024 Sep 25.
|
| [6] |
Li ZJ, Zhang HY, Ren LL, et al. Etiological and epidemiological features of acute respiratory infections in China[J]. Nat Commun, 2021, 12(1): 5026-5038. doi: 10.1038/s41467-021-25120-6.
|
| [7] |
史春亮, 梁红雷, 张勇, 等. 2023年12月-2024年4月山西省临汾市人民医院流感样病例病原监测及流行病学特征分析[J]. 中国病毒病杂志, 2024, 14(6): 541-546. doi: 10.16505/j.2095-0136.2024.0082.
|
| [8] |
曹艳, 陈雨, 伊洁, 等. 北京地区2023-2024年秋冬季急性呼吸道感染疾病的病原体流行情况分析:以北京协和医院5556例患者为例[J]. 协和医学杂志, 2025, 16(3):680-686. doi:10.12290/xhyxzz.2024-0529.
|
| [9] |
Wu A, Mihaylova VT, Landry ML, et al. Interference between rhinovirus and influenza A virus: A clinical data analysis and experimental infection study[J]. Lancet Microbe, 2020, 1(6): e254-e262. doi: 10.1016/s2666-5247(20)30114-2.
pmid: 33103132
|
| [10] |
Dee K, Goldfarb DM, Haney J, et al. Human rhinovirus infection blocks severe acute respiratory syndrome coronavirus 2 replication within the respiratory epithelium: Implications for COVID-19 epidemiology[J]. J Infect Dis, 2021, 224(1): 31-38. doi: 10.1093/infdis/jiab147.
|
| [11] |
Kaku Y, Okumura K, Padilla BM, et al. Virological characteristics of the SARS-CoV-2 JN.1 variant[J]. Lancet Infect Dis, 2024, 24(2): e82. doi: 10.1016/S1473-3099(23)00813-7.
pmid: 38184005
|
| [12] |
Dunguk HS, Holm M, Hartling U, et al. Mycoplasma pneumoniae incidence, phenotype, and severity in children and adolescents in Denmark before, during, and after the COVID-19 pandemic: A nationwide multicentre population-based cohort study[J]. Lancet Reg Health Eur, 2024, 47(10):110-123. doi: 10.1016/j.lanepe.2024.101103.
|
| [13] |
Bai L, Zhao Y, Dong J, et al. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity[J]. Cell Res, 2021, 31(4): 395-403. doi: 10.1038/s41422-021-00473-1.
pmid: 33603116
|